Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Gastric Cancer, Immunotherapy and Chemotherapy

Manish Shah

MD

🏢Weill Cornell Medicine🌐USA

Director of Gastrointestinal Oncology

58
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Manish Shah at Weill Cornell Medicine is a leading gastric and gastroesophageal junction cancer specialist who has contributed to pivotal immunotherapy trials in gastric cancer including KEYNOTE and CHECKMATE series. His research spans HER2-targeted therapy, immunotherapy, and chemotherapy combinations in upper GI malignancies. He has been involved in clinical investigations of trastuzumab deruxtecan in gastric cancer and has contributed to understanding molecular subtypes of GEJ cancer. His translational work has focused on identifying biomarkers that predict immunotherapy benefit in gastric cancer beyond PD-L1.

Share:

🧪Research Fields 研究领域

gastric cancer immunotherapy
nivolumab gastric CHECKMATE
pembrolizumab gastric KEYNOTE
gastroesophageal junction cancer treatment
HER2 gastric clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Manish Shah 的研究动态

Follow Manish Shah's research updates

留下邮箱,当我们发布与 Manish Shah(Weill Cornell Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment